Neoadjuvant Imatinib in Recurrent/Metastatic Gastrointestinal Stromal Tumors: A Systematic Review and Meta-analysis of Proportions.

J Gastrointest Cancer · 2025 · PMC11947046 · PMID 40140195

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

A high level of heterogeneity is demonstrated ( I 2 = 74%, p < 0.01) across the reported R0 resection outcomes, while subgroup analysis by study design and geographic region revealed no statistically significant and marginally significant differences between groups, respectively (Supplementary Figs. 1 and 2).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.